Developing Combination Therapies in Type 1 Diabetes

קרןJuvenile Diabetes Research Foundation (JDRF)
סוגResearch Grants
תאריך אחרון17/11/2021
פקולטהEngineering, Life Sciences, Medicine

LOI’s are sought for preclinical and/or clinical studies with novel approaches toward the development of combination therapies which utilize multiple therapeutic agents targeting mechanisms involved in the following biological pathways: immune modulation (including antigen specific targeting), beta cell function and regeneration/replication, and/or metabolic control.

Objective 1: Identification of novel combination therapy for T1D through predictive modeling.

Objective 2: Preclinical testing of novel combination therapy approaches for T1D.

Objective 3: Clinical testing of novel combination therapy approaches for T1D.


Only projects with relevance to T1D will be considered.
Funding: Objective 1- $150,000 per year; Objective 2- $300,000 per year; Objective 3- $500,000 per year 
Duration: Objectives 1 or 2- 2 years; Obejctive 3- 3 years
Research Authortiy due date: 10.11.21
LOI (required) due date: 17.11.21
Full proposal due date: 21.1.22
קבצים מצורפים
עדכון אחרוןעדכון אחרון: 25/10/2021
אוניברסיטת תל אביב עושה כל מאמץ לכבד זכויות יוצרים. אם בבעלותך זכויות יוצרים בתכנים שנמצאים פה ו/או השימוש
שנעשה בתכנים אלה לדעתך מפר זכויות, נא לפנות בהקדם לכתובת שכאן >>